Defense Advanced Research Projects Agency (DARPA)
675 N Randolph Street
30 articles with Defense Advanced Research Projects Agency (DARPA)
eFFECTOR and Quantitative Biosciences Institute (QBI) at UCSF Receive $5.0 Million from DARPA to Evaluate Zotatifin in COVID-19Funding will support planned Phase 1b anti-viral study in patients with mild to moderate COVID-19 infections
eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulator inhibitors for the treatment of cancer, announced a $5.0 million cooperative agreement sponsored by the Defense Advanced Research Projects Agency and the Defense Health Agency to fund a planned Phase 1b study of zotatifin as an anti-viral agent in an outpatient setting for those with mild to moderate COVID-19 disease.
Ginkgo Bioworks, Azitra, Florida International University, and Latham BioPharm Group Awarded $15M by DARPA to Develop Skin Microbiome-based Mosquito Repellent
Ginkgo Bioworks, Azitra, Inc., Florida International University, and Latham BioPharm Group have been awarded a contract by the Defense Advanced Research Projects Agency for up to $15M, as part of its ReVector program.
A Battelle team of researchers has received funding to continue work on the second of a three-phase Defense Advanced Research Projects Agency (DARPA) program called Next-Generation Nonsurgical Neurotechnology (N3). The program is designed for teams around the country to develop a high-performance, bi-directional brain-computer interface (BCI) for noninvasive clinical applications or for use by able-bodied members
INOVIO to Develop DNA-encoded Monoclonal Antibody (dMAb®) Candidates to Treat COVID-19 with Funding from the Defense Advanced Research Projects Agency (DARPA)
- DARPA to fund innovative public-private partnership between INOVIO, The Wistar Institute, AstraZeneca, the University of Pennsylvania and Indiana University - $37.6 million grant from DARPA will leverage AstraZeneca's monoclonal antibody and INOVIO's DNA-encoded monoclonal antibody (dMAb®) technologies in the fight against COVID-19
DARPA Awards Inflammatix up to $1.1 Million to Develop Diagnostic That Predicts COVID-19 Severity Risk
New Data Shows Inflammatix Machine Learning-Based Approach of Reading Immune System is Superior to IL-6 and Other Measures in Predicting Patients at High Risk for Severe COVID-19 BURLINGAME, Calif.--( BUSINESS WIRE )-- Inflammatix , a pioneering molecular diagnostics company, announced today that the Defense Advanced Research Projects Agency (DARPA) has awarded the company up to $1.1 million for further development of a rapid diagnostic that reads
DARPA Contracts with Duality Technologies to Develop Privacy-Preserving Machine Learning for COVID-19 Research
Duality Technologies partners with Harvard Medical School and Two Six Labs to accelerate privacy-preserving, collaborative machine learning protected through Homomorphic Encryption. This capability supports research into COVID-19 susceptibility while keeping patient data private and secure. [20-July-2020] NEWARK, N.J. , July 20, 2020 /PRNewswire/ -- Duality Techno
Battelle has won an Associated Contractor Agreement for a new Defense Advanced Research Projects Agency Epigenetic Characterization and Observation program.
Biomimicry, looking at how things are done in nature and applying that to solve problems, is utilized by many researchers. BioSpace looks at some examples of how scientists are performing cutting-edge research using biomimicry.
MBio Diagnostics, Inc. today announced a contract with the US Defense Advanced Research Projects Agency (DARPA) entitled, “Point-of-care Monitoring of the Host-Pathogen Interaction During Infection.”
Amyris, Inc. Announces Multi-Year Technology Investment Agreement With Defense Advanced Research Projects Agency Worth Up To $35 Million
Inovio Pharma Receives $24 Million Option Grant From Defense Advanced Research Projects Agency To Advance Ebola Program Development
Inovio Pharmaceuticals Selected By Defense Advanced Research Projects Agency To Lead A $45 Million Program To Expedite Development Of Novel Products To Prevent And Treat Disease Caused By Ebola
Defense Advanced Research Projects Agency Funds George Washington University; SRI International; Protea Biosciences, Inc. ; And GE Global Research Are Partners
Defense Advanced Research Projects Agency's Spending $70 Million on a Brain Chip for Mentally Ill Soldiers
Moderna Therapeutics Grabs $25 Million Defense Advanced Research Projects Agency Grant to Develop Messenger RNA Therapeutics
Defense Advanced Research Projects Agency Grants $23 Million Contract to Battelle, NxStage Medical, Inc. and Aethlon Medical for a Sepsis Treatment
Arsenal Medical’s Foam Technology for Battlefield Injuries Receives $15.5 Million Phase II Defense Advanced Research Projects Agency Contract
National Institutes of Health (NIH) and Defense Advanced Research Projects Agency Kick Off $132 Million Effort to Create "Human on a Chip"